Earnings call: Elekta reports mixed results, eyes future growth

In a recent earnings call, Elekta (EKTAB), a leading provider of precision radiation therapy solutions, reported a full-year net sales increase of 5% despite a 2% decline in the fourth quarter. The company’s adjusted EBIT margin rose to 11.8% for the full year but faced a drop in Q4, attributed to inflation and increased operating […]

Sign Up Now

Please enable JavaScript in your browser to complete this form.
Signing up means you agree to our Terms of Use and acknowledge our Privacy Policy.

Get Latest Price

Get explicit pricing details

Download Brochure

Register here & get all the details right now.